Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab

by Despoina Florou, Maria Katsara, Jack Feehan, Efthimios Dardiotis, Vasso Apostolopoulos
Published 2020-10-01

Multiple Sclerosis: Immunopathology and Treatment Update

by Narges Dargahi, Maria Katsara, Theodore Tselios, Maria-Eleni Androutsou, Maximilian de Courten, John Matsoukas, Vasso Apostolopoulos
Published 2017-07-01